On Demand Webinar: Looking to develop a high quality, high titer manufacturing cell line?

Published: 24.06.2020

We have developed our SPOT™ technology alongside our proprietary CHO cell line to increase the cell line specific productivity (Qp) which facilitates high volumetric productivity at low VCD accompanied with a simple and efficient DSP process. Watch our on demand webinar now to find out more.


written by: Polpharma Biologics

Let’s collaborate and deliver quality biosimilars together.

Get in touch for more information.